Pacira Biosciences Q2 Revenue USD 192.4 Million Vs. IBES Estimate USD 190.8 Million
PCRX•Quarterly results
Aug. 4 (Reuters) - Pacira Biosciences Q2 adjusted EBITDA was USD 48.7 million.
- Q2 net income was USD 4.7 million
- Q2 cash & investments were USD 251 million
- Q2 adjusted net income was USD 29.5 million vs. IBES estimate of USD 27.3 million
